Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-08-30
1992-06-23
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
568824, 514545, 514547, 514549, 514725, 554116, 554118, 560 51, 560 54, 560126, C11C 302
Patent
active
051240831
ABSTRACT:
There are disclosed 3-substituted and 3,3-disubstituted all-trans-4-oxoretinoic acids and 3-substituted and 3,3-disubstituted 13-cis-4-oxoretinoic acids and their lower alkyl esters.
REFERENCES:
Shealy, Preventive Medicine, vol. 18, pp. 624-645, 1989.
Roberts and Frolik, Federation Proceedings, vol. 38, No. 11, pp. 2524-2527, 1979.
Roberts et al, Archives of Biochemistry and Biophysics, vol. 199, No. 2, pp. 374-383, 1980.
Frolik, The Retinoids, vol. 2, edited by M. B. Sporn, A. B. Roberts and D. S. Goodman, Academic Press, Inc. Orlando, Fla., 1984, pp. 177-208.
Carr Deborah D.
Dees Jos,e G.
Southern Research Institute
LandOfFree
3-substituted and 3,3-disubstituted 4-oxoretinoic acids and thei does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-substituted and 3,3-disubstituted 4-oxoretinoic acids and thei, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted and 3,3-disubstituted 4-oxoretinoic acids and thei will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-931376